02.01.2015 Views

Remicade Order Form - Florida Health Care Plans

Remicade Order Form - Florida Health Care Plans

Remicade Order Form - Florida Health Care Plans

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

FLORIDA HEALTH CARE PLANS<br />

REMICADE ORDER<br />

Date: Auth. #:<br />

A. Member Name: Referring Provider Name:<br />

Med. Record #: Date of Birth: Referring Provider Phone #:<br />

Home Phone#: Work Phone# Referring Provider FHCP #:<br />

Cell #:<br />

Subscriber #:<br />

Parent/Guardian Name:<br />

Provider Signature:<br />

Copy to:<br />

Allergies:<br />

Type of Referral: URGENT ROUTINE<br />

Administer PPD Weight DIAGNOSIS CODE<br />

REMICADE Dose<br />

Frequency<br />

Pre-medicate with:<br />

NONE<br />

Benadryl 25mg PO Benadryl 50mg PO Repeat as needed.<br />

Tylenol 650mg PO Repeat as needed<br />

Prednisone 40mg PO Prednisone 40mg IV Other<br />

If B/P decreases between 15 & 20 mmHg, or patient experiences symptoms indicating Hypersensitivity<br />

(urticaria, dyspnea, hypotension, heart rate decrease, dizziness, chest pain) stop infusion and give<br />

Benadryl 25mg PO Benadryl 50mg PO Repeat as needed<br />

Tylenol 650mg PO Prednisone 40mg Po Prednisone 40mg IV<br />

Other<br />

* Refer to Centocor Algorithm for <strong>Remicade</strong><br />

____________________________<br />

Physician Signature<br />

REASON FOR REFERRAL: (Attach all supporting documentation)<br />

THIS SECTION IS ONLY FOR THOSE SERVICES THAT REQUIRE PRE-AUTHORIZATION<br />

This <strong>Form</strong> is intended to represent the Provider’s order as well as the Services that have been approved by FHCP. Payment will not be<br />

authorized for services beyond those as indicated below. Authorization for additional services must be coordinated through the Member’s<br />

PCP or the Referring Provider.<br />

APPROVED BY FLORIDA HEALTH CARE PLANS FOR:<br />

Signature:<br />

Date:<br />

TO: FROM: Phone #:<br />

This document is privileged and confidential. It is intended solely for the use of the recipient named above. If the reader/recipient of this document is not the intended recipient,<br />

you are hereby notified that any distribution, copying or disclosure of the contents of this document is prohibited. If you have received this document in error, please notify<br />

FHCP immediately by the telephone or fax number indicated above and return the original facsimile message to us at P. O. Box 9910, Daytona Beach, FL 32120.<br />

21-110/10-07RX


PROCEDURE FOR ORDERING REMICADE<br />

<strong>Remicade</strong> is a monoclonal antibody agent known to be effective in the treatment of Crohn’s Disease and Rheumatoid<br />

Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, and Psoriatic Arthritis.<br />

Approval for treatment of Crohn’s Disease is based on failure of both an anti-inflammatory agent (5-ASA compounds,<br />

sulfasalazine, Dipentum, Pentasa, Asacol & Rowasa) and an immunosuppressant (purinethol, azothioprine,<br />

methotrexate). Intermittent steroids and antibiotics used to manage exacerbations and maintain remission are not<br />

sufficient to satisfy immunosuppressant and anti-inflammatory trials.<br />

Approval for treatment of Ulcerative Colitis is based on history of moderate to severe ulcerative colitis in patients who<br />

have contraindications to or have failed both therapeutically effective doses of Aminosalicilates (sulfasalizine 4-<br />

6g/day, mesalamine 2-4.8g/day, balsalazide 6.75g/day, olsalazine 1.5-3g/day), and an Immunomodulator (6-<br />

mercaptopurine or azothioprine) or continuous corticosteroid. Approved injections will be covered at weeks 0,2,6, and<br />

then every 8 weeks at the labeled dosage (5mg/kg).<br />

Approval for treatment of rheumatoid arthritis (RA), And Psoriatic Arthritis is based on failure of Humira (2 nd in line<br />

to Enbrel failures). Note: <strong>Remicade</strong> is only indicated for treatment of RA in combination with methotrexate.<br />

PROCEDURE:<br />

• <strong>Order</strong>ing physician will send completed <strong>Remicade</strong> order (form 21-110) and supporting documentation to the<br />

FHCP Referral Department<br />

• <strong>Order</strong> must include dose of REMICADE, frequency, Pre-medication order and orders to follow if reaction to<br />

infusion<br />

• Documentation of PPD within one year or order for PPD before first treatment.<br />

• If approved, Referral Department will notify physician office and send signed form to FHCP Infusion Clinic:<br />

‣ Daytona Facility<br />

‣ Orange City Facility<br />

‣ Palm Coast Facility<br />

‣ Edgewater Facility<br />

• Infusion Clinic will call patient to set up appointment for PPD<br />

• Infusion Clinic Nurse will place and read PPD, and assess for any s / s infection<br />

• If patient has a previous positive PPD, order chest x-ray with copy to Infusion Clinic<br />

• Infusion nurse will assess for signs and symptoms of TB and document on nurse assessment and <strong>Remicade</strong><br />

order form<br />

• Infusion Clinic Nurse will send order for <strong>Remicade</strong> to Pharmacy<br />

• Clinic will schedule patient for appointment for <strong>Remicade</strong> infusion<br />

• Medicare patients will pick up medication at Pharmacy and bring with him/her to appointment at Infusion<br />

Clinic, all other members <strong>Remicade</strong> will be shipped to infusion clinic.<br />

• <strong>Order</strong>ing physician will provide patient with information and educational materials<br />

21-110/10-07RX

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!